2'-Fucosyllactose

DB16052InvestigationalSmall molecule

2'-Fucosyllactose is under investigation in clinical trial NCT03847467 (Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-tnf Therapy).

Mechanism: Pharmacologically active on Toll-like receptor 4
Curator reviewed
Formula / weight: C₁₈H₃₂O₁₅ · 488.439 g/mol (avg)
Code names: 2'FL

Resolves to

Compound

UNIIXO2533XO8RCAS41263-94-9ChEMBLCHEMBL4297252

Clinical / RWD

RxNorm1733688

Structure

InChIKeyHWHQUWQCBPAQQH-BWRPKUOHSA-NSMILES

[H][C@@](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O[C@]1([H])O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O)([C@H](O)CO)[C@H](O)[C@@H](O)C=O

Targets

O00206TLR4

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with 2'-Fucosyllactose, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account